Connect with us

Healthcare Buzz

GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore

GlaxoSmithKline Pharmaceuticals has reported a 16.56 percent rise in its standalone net profit to Rs 123.03 crore for the quarter ended March 31, 2019. The company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal. Its standalone revenue from operations stood at Rs 751.22 crore for the quarter under consideration. It was Rs 748.62 crore for the corresponding quarter a year ago.

For the fiscal year ended March this year, the company posted a net profit of Rs 425.36 crore as against Rs 351.98 crore for the previous fiscal year. Standalone revenue from operations for the fiscal year ended March 2019 stood at Rs 3128.53 crore. It was Rs 2895.88 crore for the year-ago fiscal. The company’s board has recommended a dividend of Rs 20 per equity share on a face value of Rs 10 each for the year ended March 31.

Copyright © 2024 Medical Buyer

error: Content is protected !!